Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K053185
    Manufacturer
    Date Cleared
    2006-01-24

    (71 days)

    Product Code
    Regulation Number
    870.1130
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K001898

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Primo™ Noninvasive Blood Pressure Measurement System is a hand held non-invasive blood pressure measurement system intended to be used on adult patients with wrist circumferences of 11 cm - 22 cm by trained medical personnel to measure systolic, diastolic blood pressure and pulse rate.

    Device Description

    The Primo™ Noninvasive Blood Pressure Measurement System is a hand-held non-invasive blood pressure measurement system that measure systolic, diastolic blood pressure and pulse rate from the user's wrist. The system is contained in hard plastic housings that contain a user interface panel and a wrist sensor. The characteristics of the arterial waveforms are recorded with a unique pressure sensor that is placed over the radial artery. This system provides a single reading of blood pressure, using a pressure sensor placed on the wrist over the radial artery. This sensor is noninvasive.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the Medwave, Inc. Primo™ Noninvasive Blood Pressure Measurement System, based on the provided text:

    Acceptance Criteria and Device Performance

    Acceptance Criteria (Standard)Reported Device Performance (Primo™)
    Mean difference of ± 5mmHg or less (Systolic/Diastolic Blood Pressure)Mean difference of ± 5mmHg or less (for both systolic and diastolic blood pressure)
    Standard deviation of 8mmHg or less (Systolic/Diastolic Blood Pressure)Standard deviation of 8mmHg or less (for both systolic and diastolic blood pressure)
    Pulse measurement accuracy of ± 5 bpm or 10% of measured pulse frequencyPulse measurement accuracy of ± 5 bpm or 10% of the measured pulse frequency
    Operating Temperature Conditions 10°C (50°F) - 40°C (104°F)10°C - 40°C
    Operating Humidity Conditions 15-90 percent (noncondensing)10% to 85% relative humidity
    Life test minimum of 10,000 full-scale cyclesTested and successfully completed
    Electrical safety (IEC60601)Tested and successfully completed
    Biocompatibility (ISO10993-1)Tested and successfully completed
    Electromagnetic CompatibilityTested and successfully completed

    Note: Many acceptance criteria listed in the table (e.g., Device Labeling, Storage Conditions, Vibration and Shock, Software Testing, etc.) refer to various standards (ANSI/AAMI SP10-2002, IEC60601, CDRH Guidance Document, NSTA, Medwave internal documents) and are stated as "X" or "Tested and successfully completed," indicating compliance. The table above focuses on the quantitative performance metrics explicitly stated.


    Study Information

    Here's the detailed information about the study that proves the device meets the acceptance criteria:

    1. Sample Size Used for the Test Set and Data Provenance:

      • Sample Size: Not explicitly stated in the provided text. The text mentions "an extensive collection of tests" and "study results in the supporting Clinical Data on file at Medwave, Inc." (for pulse accuracy) and "study results in Appendix H" (for blood pressure accuracy against intra-arterial lines), but does not give specific numbers for the test set.
      • Data Provenance: Not explicitly stated. The document does not specify the country of origin of the data or whether it was retrospective or prospective.
    2. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications:

      • Not explicitly stated. The document mentions that the algorithms were "tested against intra arterial line pressure waveforms," which implies a direct physiological measurement as ground truth rather than expert interpretation of images or other data.
    3. Adjudication Method for the Test Set:

      • Not applicable/Not stated. Since the ground truth primarily relies on intra-arterial line pressure waveforms, an adjudication method for expert consensus is not described.
    4. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

      • Was it done? No. The document does not mention any MRMC study or comparison of human readers with and without AI assistance for this device. This is a standalone device measuring physiological parameters directly.
      • Effect size of human readers improving with AI vs without AI assistance: Not applicable, as no such study was described.
    5. Standalone (Algorithm Only Without Human-in-the-Loop Performance):

      • Was it done? Yes. The entire description of the performance testing focuses on the device's accuracy in measuring blood pressure and pulse rate (algorithm only performance). The device is a "hand-held non-invasive blood pressure measurement system" that provides "a single reading." The algorithms' performance is directly assessed against intra-arterial line pressure waveforms.
    6. Type of Ground Truth Used:

      • Intra-arterial line pressure waveforms. The document explicitly states: "The algorithms have been tested against intra arterial line pressure waveforms and proven to meet industry standards..."
    7. Sample Size for the Training Set:

      • Not explicitly stated. The document refers to "Medwave's proprietary algorithms" and states they have been "tested against intra arterial line pressure waveforms," but does not provide information about the training set size for these algorithms.
    8. How the Ground Truth for the Training Set Was Established:

      • Not explicitly stated for the training set. However, given that the algorithms were tested against intra-arterial line pressure waveforms, it is highly probable that similar intra-arterial line pressure data would have been used as ground truth for establishing and refining these proprietary algorithms during their development/training phase. The document does not detail this process explicitly.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1